Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.59 |
| ▸ | EPHX1 | P07099 | 9/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.49 |
| ▸ | PRCP | P42785 | 2/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.44 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.44 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9518381 | 0.87 | SIGMAR1 (0.49) | NAAASIGMAR1 | |
| Iodide SCHEMBL9427758 | 0.85 | SIGMAR1 (0.47) | NAAASIGMAR1 | |
| SCHEMBL27434311 | 0.83 | SIGMAR1 (0.42) | NAAAEPHX1EPHX2SIGMAR1 | |
| SCHEMBL17187465 | 0.77 | EPHX1 (0.60) | NAAAEPHX1EPHX2SIGMAR1 | |
| SCHEMBL9543418 | 0.77 | EPHX1 (0.60) | NAAAEPHX1EPHX2SIGMAR1 | |
| SCHEMBL17187474 | 0.77 | EPHX1 (0.60) | NAAAEPHX1EPHX2SIGMAR1 | |
| SCHEMBL17187416 | 0.77 | EPHX1 (0.60) | NAAAEPHX1EPHX2SIGMAR1 | |
| SCHEMBL18428870 | 0.77 | EPHX1 (0.60) | NAAAEPHX1EPHX2SIGMAR1 | |
| SCHEMBL17187505 | 0.77 | EPHX1 (0.60) | NAAAEPHX1EPHX2SIGMAR1 | |
| SCHEMBL17187473 | 0.77 | EPHX1 (0.60) | NAAAEPHX1EPHX2SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1993016173-A1 | DECOLORIZATION AND DEODORIZATION OF FERMENTATION BROTH BY TREATMENT WITH STRONGLY BASIC EXTRACTANTS | COGNIS, INC. (US) | 1993-08-19 | — | — | WO | disclosed |